Compliance Management

U.S. DOJ Charges 14 with Sale of $78M in Counterfeit Drugs

Aug 19, 2015

Securing Industry

In a U.S. Department of Justice (DOJ) indictment handed down in November last year and unsealed on Aug. 11, 2015, director of pharmacy policy and international verifications for PharmacyChecker.com, Ram Kamath, PharmD and CanadaDrugs.com are among 14 people and companies charged with crimes related to the sale of $78 million worth of mislabeled and counterfeit prescription drugs, according to a PRNewswire article. The charges included smuggling, improper storage, falsifying customs declarations, money laundering and conspiracy.

Kamath will be arraigned in a U.S. federal court on August 25, the article said. The other defendants are located outside the United States and have not yet been extradited. According to the DOJ indictment, Canada Drugs and its affiliates illegally purchased the mislabeled and counterfeit drugs abroad and then routed them through Egypt and Barbados for sale to doctors in the U.S.

Read the Securing Industry news